A. J. Garber

4.4k citations

58 papers · 3.4k indexed · h-index 26

Endocrinology, Diabetes and Metabolism top 0.5%
Molecular Biology top 10%
Physiology top 2%
Surgery top 5%
Cell Biology top 5%

Co-authors: David Kipnis Irene E. Karl Michelle A. Baron Erika Rochotte S. Dejager Morey W. Haymond Philip E. Cryer Anja Schweizer
Topics: Diabetes Treatment and Management (33 papers)Metabolism, Diabetes, and Cancer (20 papers)Diabetes Management and Research (19 papers)
Cited by: Endocrinology, Diabetes and Metabolism Physiology Clinical Biochemistry
Journals: Journal of Biological Chemistry Journal of Clinical Investigation American Journal of Clinical Nutrition
Partner nations: United States Denmark Italy

In The Last Decade

A. J. Garber

57 papers receiving 3.1k citations

Peers

Countries citing papers authored by A. J. Garber

Since Specialization

Citations

This map shows the geographic impact of A. J. Garber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. J. Garber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. J. Garber more than expected).

Fields of papers citing papers by A. J. Garber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. J. Garber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. J. Garber. The network helps show where A. J. Garber may publish in the future.

Co-authorship network of co-authors of A. J. Garber

This figure shows the co-authorship network connecting the top 25 collaborators of A. J. Garber. A scholar is included among the top collaborators of A. J. Garber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. J. Garber. A. J. Garber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents 2013 ·Diabetes Obesity and Metabolism ·Athena Philis‐Tsimikas,Stefano Del Prato,İlhan Satman,Anuj Bhargava,Mala Dharmalingam,Trine Vang Skjøth,Søren Rasmussen,A. J. Garber	31
2	Obesity and type 2 diabetes: which patients are at risk? 2011 ·Diabetes Obesity and Metabolism ·A. J. Garber	83
3	Liraglutide, a once‐daily human glucagon‐like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes 2010 ·Diabetes Obesity and Metabolism ·A. J. Garber,Robert R. Henry,Robert E. Ratner,Paula M. Hale,Cheng‐Chieh Chang,Bruce W. Bode	156
4	Restaging insulin therapy for patients with type 2 diabetes 2009 ·Diabetes Obesity and Metabolism ·A. J. Garber	6
5	Weight loss with liraglutide, a once‐daily human glucagon‐like peptide‐1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue 2009 ·Diabetes Obesity and Metabolism ·Johan Jendle,Michael A. Nauck,David R. Matthews,Anders Frid,Kjeld Hermansen,Maria Düring,Marija Zdravković,Boyd J. Strauss,A. J. Garber,(unknown)	247
6	Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis 2009 ·Canadian Journal of Diabetes ·Jorge Plutzky,A. J. Garber,A Falahati,(unknown),Neil R Poulter	27
7	The reduction of body weight with liraglutide, a once-daily human GLP-I analogue for type 2 diabetes, primarily comes from fat tissue and the fat tissue lost is predominantly visceral fat 2008 ·Lund University Publications (Lund University) ·Johan Jendle,Michael A. Nauck,D. M. Matthews,Anders Frid,Kjeld Hermansen,(unknown),Marija Zdravković,Boyd J. Strauss,A. J. Garber	3
8	Initial treatment with rosiglitazone/metformin fixed‐dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes 2006 ·Diabetes Obesity and Metabolism ·J Rosenstock,(unknown),Alexander R. Cobitz,N. Biswas,Hubert S. Chou,A. J. Garber	69
9	Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo‐controlled study* 2006 ·Diabetes Obesity and Metabolism ·A. J. Garber,Anja Schweizer,Michelle A. Baron,Erika Rochotte,S. Dejager	241
10	Insulin therapy in type 2 diabetes patients failing oral agents: cost‐effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US* 2006 ·Diabetes Obesity and Metabolism ·Joshua Ray,William J. Valentine,S Roze,L Nicklasson,D Cobden,Philip Raskin,A. J. Garber,Andrew Palmer	23
11	Improvement in glycaemic control with rosiglitazone/metformin fixed‐dose combination therapy in patients with type 2 diabetes with very poor glycaemic control 2006 ·Diabetes Obesity and Metabolism ·Julio Rosenstock,(unknown),Alexander R. Cobitz,Chih‐Yang Huang,A. J. Garber	30
12	Metformin‐glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy 2005 ·Diabetes Obesity and Metabolism ·A. J. Garber,E. Klein,Simon Bruce,Serap Sankoh,Pharis Mohideen	62
13	Metformin and vascular protection: a diabetologist's view 2003 ·Diabetes & Metabolism ·A. J. Garber	4
14	Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single‐tablet metformin–glibenclamide therapy (Glucovance®) in type 2 diabetes 2003 ·Diabetes Obesity and Metabolism ·A. J. Garber,Michel Marre,Lawrence Blonde,(unknown),H. C. S. Howlett,Philippe Lehert,Michael P. Cornes	21
15	Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats 2002 ·Biochemical and Biophysical Research Communications ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Sook Hee Hong,Tae-Ho Hwang,Do‐Young Kang,A. J. Garber,(unknown)	96
16	Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes 2002 ·Diabetes Obesity and Metabolism ·A. J. Garber,Jennifer L. Larsen,Stephen H. Schneider,(unknown),David Henry,(unknown)	104
17	Implications of cardiovascular risk in patients with type 2 diabetes who have abnormal lipid profiles: is lower enough? 2000 ·Diabetes Obesity and Metabolism ·A. J. Garber	3
18	Magnesium utilization survey in selected patients with diabetes 1996 ·Clinical Therapeutics ·A. J. Garber	4
19	Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease 1989 ·Neurology ·Joseph Jankovic,Robert Grossman,Carl B. Goodman,Francis J. Pirozzolo,(unknown),(unknown),P.T. Scardino,A. J. Garber,Satish G. Jhingran,Seán Martin	73
20	Substrate and hormonal responses to hypoglycemia in man 1975 ·Diabetes ·A. J. Garber,Philip Cryer,Julio V. Santiago	1

About A. J. Garber

A. J. Garber is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry and Cell Biology, having authored 58 papers that have together received 3.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (33 papers), Metabolism, Diabetes, and Cancer (20 papers) and Diabetes Management and Research (19 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.1k citations), Physiology (854 citations) and Clinical Biochemistry (214 citations). A. J. Garber has collaborated with scholars based in United States, Denmark and Italy. Frequent co-authors include David Kipnis, Irene E. Karl, Michelle A. Baron, Erika Rochotte, S. Dejager, Morey W. Haymond, Philip E. Cryer, Anja Schweizer, Julio V. Santiago and Anthony S. Pagliara. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and American Journal of Clinical Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact